HomeCompareAGTC vs KMB

AGTC vs KMB: Dividend Comparison 2026

AGTC yields 508.13% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGTC wins by $69571.52M in total portfolio value
10 years
AGTC
AGTC
● Live price
508.13%
Share price
$0.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69571.56M
Annual income
$50,154,845,926.92
Full AGTC calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — AGTC vs KMB

📍 AGTC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGTCKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGTC + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AGTC pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGTC
Annual income on $10K today (after 15% tax)
$43,191.06/yr
After 10yr DRIP, annual income (after tax)
$42,631,619,037.88/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, AGTC beats the other by $42,631,614,598.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGTC + KMB for your $10,000?

AGTC: 50%KMB: 50%
100% KMB50/50100% AGTC
Portfolio after 10yr
$34785.80M
Annual income
$25,077,425,574.63/yr
Blended yield
72.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AGTC right now

AGTC
Analyst Ratings
9
Buy
5
Hold
Consensus: Buy
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGTC buys
0
KMB buys
0
No recent congressional trades found for AGTC or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGTCKMB
Forward yield508.13%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$69571.56M$45.9K
Annual income after 10y$50,154,845,926.92$5,222.34
Total dividends collected$67890.24M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: AGTC vs KMB ($10,000, DRIP)

YearAGTC PortfolioAGTC Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$61,513$50,813.01$11,314$614.45+$50.2KAGTC
2$357,937$292,117.85$12,867$760.19+$345.1KAGTC
3$1,971,589$1,588,596.72$14,713$945.27+$1.96MAGTC
4$10,287,466$8,177,865.69$16,924$1,181.90+$10.27MAGTC
5$50,886,951$39,879,362.52$19,596$1,486.64+$50.87MAGTC
6$238,807,233$184,358,195.45$22,850$1,882.16+$238.78MAGTC
7$1,064,097,636$808,573,896.33$26,849$2,399.80+$1064.07MAGTC
8$4,505,792,438$3,367,207,967.63$31,812$3,083.36+$4505.76MAGTC
9$18,146,463,265$13,325,265,356.46$38,033$3,994.72+$18146.43MAGTC
10$69,571,561,621$50,154,845,926.92$45,918$5,222.34+$69571.52MAGTC

AGTC vs KMB: Complete Analysis 2026

AGTCStock

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.

Full AGTC Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this AGTC vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGTC vs SCHDAGTC vs JEPIAGTC vs OAGTC vs KOAGTC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.